title: Use of inhaled ampicillin-sulbactam against multiresistant Acinetobacter baumannii in bronchial secretions of intensive care unit patients.
authors.forename: M
authors.initials: M
authors.lastname: Horianopoulou
authors.forename: M
authors.initials: M
authors.lastname: Kanellopoulou
authors.forename: I
authors.initials: I
authors.lastname: Paraskevopoulos
authors.forename: A
authors.initials: A
authors.lastname: Kyriakidis
authors.forename: N J
authors.initials: NJ
authors.lastname: Legakis
authors.forename: S
authors.initials: S
authors.lastname: Lambropoulos
mesh_terms: D000150:Acinetobacter / Q000187:drug effects; D000151:Acinetobacter Infections / Q000188:drug therapy*; D000280:Administration, Inhalation; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001980:Bronchi / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012121:Respiration, Artificial; D013407:Sulbactam / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D000667:Ampicillin; D013407:Sulbactam